Company Profiles

driven by the PitchBook Platform

NeuroTrax

Description

Developer of computerized diagnostic cognitive testing. The company focuses on novel and technologically advanced methods for assessment of neurocognitive disorders, developing testing solutions that can be administered in an office environment

PRIVATE

Status

Series B

Latest Deal Type

$1.5M

Latest Deal Amount

$1.71M

Total Amount Raised

1

Investors

Description

Developer of computerized diagnostic cognitive testing. The company focuses on novel and technologically advanced methods for assessment of neurocognitive disorders, developing testing solutions that can be administered in an office environment

Website:

www.neurotrax.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Vertical Market Software

Primary Office

POB 226 Modiin 71711Israel +972 (0)72 220 1180
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore NeuroTrax's full profile, request a free trial.

NeuroTrax Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

NeuroTrax Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

NeuroTrax Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
New Jersey Economic Development AuthorityGovernmentMinority000 0000000 0000
New Jersey Economic Development Authority Government

NeuroTrax Executive Team (1)

NameTitleBoard
Seat
Contact
Info
Robert PepperChief Executive Officer
Robert Pepper Chief Executive Officer
Request full access to PitchBook